Breaking News
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free
Close

Crispr Therapeutics AG (CRSP)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Crispr Therapeutics's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
63.16 -1.74    -2.68%
23/09 - Closed. Currency in USD ( Disclaimer )
Pre Market
62.20
-0.96
-1.52%
5:16:54 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 1,089,098
  • Bid/Ask: 60.55 / 67.00
  • Day's Range: 61.78 - 64.59
Crispr Therapeutics 63.16 -1.74 -2.68%

CRSP Recent Sentiments

 
This page contains information on users’ sentiments for the Crispr Therapeutics AG stock, which are displayed both on charts of different periods of time and on a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Sep 19, 2022 Thibaud Jacob   69.03 -8.50%
Sep 09, 2022 Chang Shik Yun   66.55 -5.09%
Sep 08, 2022 Marco Borsachiotto   65.99 Sep 12, 2022 @ 66.94 +1.44%
Aug 31, 2022 فهد عبدلله   64.99 Sep 23, 2022 @ 63.16 -2.82%
Aug 25, 2022 Glenn Putzeys   72.86 Sep 16, 2022 @ 70.53 -3.20%
Aug 24, 2022 The Penguins   71.11 Sep 16, 2022 @ 70.53 -0.82%
Aug 23, 2022 ALESSANDRO RUSSI   68.67 Sep 16, 2022 @ 70.53 +2.71%
Aug 23, 2022 Rogerio Carapuca   68.93 Sep 16, 2022 @ 70.53 +2.32%
Aug 17, 2022 dongchan park   71.50 Aug 22, 2022 @ 68.07 -4.80%
Aug 16, 2022 BestBet   76.96 Aug 22, 2022 @ 68.07 -11.55%
Aug 10, 2022 Edward Hughes   77.29 Sep 02, 2022 @ 63.74 +17.53%
Aug 09, 2022 Paulo Russomanno   74.88 Aug 15, 2022 @ 78.99 -5.49%
Aug 09, 2022 Анфилогов Вячеслав   76.27 Sep 02, 2022 @ 63.74 -16.43%
Aug 09, 2022 John Brand   76.62 Sep 02, 2022 @ 63.74 -16.81%
Aug 05, 2022 David Hew   81.40 Aug 26, 2022 @ 67.37 -17.24%
Aug 05, 2022 Long John Silver   77.82 Aug 26, 2022 @ 67.37 -13.43%
Aug 04, 2022 João Fidalgo   78.12 Aug 26, 2022 @ 67.37 -13.76%
Aug 04, 2022 Flavio Costa   77.51 Aug 08, 2022 @ 82.10 +5.92%
Aug 04, 2022 Harry Karna   76.52 Aug 26, 2022 @ 67.37 -11.96%
Aug 03, 2022 אבי יחזקאל   81.71 Aug 26, 2022 @ 67.37 -17.55%
Jul 28, 2022 Giacomo Le Pera   76.12 Aug 19, 2022 @ 68.60 -9.88%
Jul 22, 2022 Asmine Lin   76.32 Aug 13, 2022 @ 78.66 +3.07%
Jul 20, 2022 Буся Ильин   83.57 Aug 13, 2022 @ 78.66 -5.88%
Jul 20, 2022 Stefano Monzani   84.75 Aug 13, 2022 @ 78.66 -7.19%
Jul 19, 2022 Claudio Cartasegna   83.52 Aug 13, 2022 @ 78.66 -5.82%
Jul 19, 2022 Toni Huser   83.34 Aug 13, 2022 @ 78.66 -5.62%
Jul 18, 2022 Nolan Beninger   82.48 Aug 13, 2022 @ 78.66 -4.63%
Jul 18, 2022 ka hus   83.31 Aug 13, 2022 @ 78.66 -5.58%
Jul 18, 2022 Gio Chiappa   85.00 Aug 13, 2022 @ 78.66 -7.46%
Jul 15, 2022 Ek Raj Thapaliya   82.39 Jul 18, 2022 @ 83.53 +1.38%
Jul 15, 2022 빅 코   81.92 Aug 05, 2022 @ 81.40 -0.63%
Jul 15, 2022 roberto zito   81.56 Aug 05, 2022 @ 81.40 -0.20%
Jul 14, 2022 Marcos Roberto Jemar   83.02 Jul 18, 2022 @ 83.53 +0.61%
Jul 13, 2022 Vlad Protiv   81.08 Aug 05, 2022 @ 81.40 +0.39%
Jul 13, 2022 용희 정   80.53 Aug 05, 2022 @ 81.40 +1.08%
Jul 12, 2022 Aniceto Rodríguez   78.77 Aug 05, 2022 @ 81.40 -3.34%
Jul 12, 2022 Gerry Goz   76.43 Jul 18, 2022 @ 83.53 +9.29%
Jul 07, 2022 Marco Borsachiotto   77.58 Jul 11, 2022 @ 74.53 -3.93%
Jul 07, 2022 João Santos   78.78 Jul 29, 2022 @ 75.00 -4.80%
Jul 07, 2022 Garret Napier   77.82 Jul 29, 2022 @ 75.00 -3.62%
Jul 06, 2022 David Hew   75.87 Jul 29, 2022 @ 75.00 -1.15%
Jul 05, 2022 Avi Cohen   71.06 Jul 29, 2022 @ 75.00 +5.54%
Jul 05, 2022 Eric Rea   70.90 Jul 29, 2022 @ 75.00 +5.78%
Jun 29, 2022 Светлана Кагадий   63.36 Jul 22, 2022 @ 75.82 +19.67%
Jun 22, 2022 Kamil Kowalski   60.23 Jun 27, 2022 @ 67.01 +11.26%
Jun 22, 2022 Brandon Low   57.96 Jul 15, 2022 @ 83.39 +43.88%
Jun 22, 2022 Theo Michaux   64.67 Jun 27, 2022 @ 67.01 +3.62%
Jun 21, 2022 Andrea Mitch Riccardi   61.02 Jul 15, 2022 @ 83.39 +36.66%
Jun 21, 2022 Diego Santana   62.05 Jun 27, 2022 @ 67.01 +7.99%
Jun 21, 2022 성준 김   73.32 Jul 15, 2022 @ 83.39 +13.73%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CRSP Comments

Write your thoughts about Crispr Therapeutics AG
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Shaun Webb
Shaun Webb May 19, 2022 3:08AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Time to load up
Billy Bilnaad
Billy Bilnaad Mar 01, 2022 10:43AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Nice price
min zhang
min zhang Jan 28, 2022 12:19PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The earning date posted here is wrong. Its 2/16/22. So miss leading
Warr Muzz
WarrMuzz Dec 17, 2021 9:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
wow... it's bucking the trend
Nuno Da Silva
Nuno Da Silva Dec 09, 2021 3:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
another cathy wood investment ¡ Good luck ...enjoy the elevator
Marco Castañeda
Marco Castañeda Nov 23, 2021 12:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
CRISPR Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to CTX110™ for the Treatment of Relapsed or Refractory CD19+ B-cell malignanciesZUG, Switzerland and CAMBRIDGE, Mass., Nov. 22, 2021 (GLOBE NEWSWIRE) http://ir.crisprtx.com/news-releases/news-release-details/crispr-therapeutics-announces-fda-regenerative-medicine-advanced
jason xx
jason xx Nov 18, 2021 2:28PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Amazing how fast this went from breakthrough life changing technology to garbage in about a month
jason xx
jason xx Nov 18, 2021 2:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
One paragraph of good news and this goes back to 160 in a day after the sheep pile in. Not just this ticker but any of them.
Benjamin Kim
Benjamin Kim Nov 06, 2021 1:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Added 1100 shares
sharad sharma
sharad sharma Nov 06, 2021 1:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
now u must be regretting
Benjamin Kim
Benjamin Kim Nov 06, 2021 1:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
nope I'm long!
Lucky Man
Lucky Man Oct 29, 2021 1:53PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
keep tanking this stock what a hopeless
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email